Table 3.
Outcome of epidural analgesia among patients undergoing hepatopancreatic surgery in propensity score-matched cohort*
Outcome | OR (95% CI) | P value |
---|---|---|
Any complication | .98 (.90–1.06) | .63 |
Sepsis | .72 (.56–.93) | .01 |
Wound infection | 1.12 (.95–1.32) | .18 |
Wound complication | 1.07 (.82–1.40) | .62 |
Postoperative hemorrhage | .81 (.65–1.01) | .06 |
Respiratory failure | .79 (.69–.91) | .001 |
Postoperative pneumonia | .77 (.61–.98) | .04 |
Cardiac complication | 1.01 (.83–1.23) | .94 |
Ileus | 1.00 (.89–1.13) | .99 |
Liver failure | .69 (.46–1.03) | .07 |
Thromboembolic event | .98 (.73–1.33) | .91 |
Postoperative shock | .90 (.56–1.47) | .69 |
Cerebrovascular accident | .91 (.26–3.19) | .88 |
Urinary tract infection | .97 (.81–1.16) | .74 |
Prolonged length of hospital stay‡ |
1.12 (1.03–1.22) | .01 |
In-hospital mortality | .72 (.56–.93) | .01 |
CI = confidence interval; OR = odds ratio.
Age, race, sex, hospital bed size, hospital location/teaching status, household income, operation type, surgical approach (open vs MIS), patient location by county, primary payer, and Charlson comorbidity index (conventional analgesia is used as the reference group).
Prolonged length of hospital stay is defined by greater than or equal to 10 days.